GuidelineThe Canadian journal of cardiology2009
2009 Canadian Hypertension Education Program recommendations: the scientific summary--an annual update.
Guideline in The Canadian journal of cardiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.
- Guideline
- Effect of an intervention to improve the cardiovascular health of family members of patients with coronary artery disease: a randomized trial.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2014Trial
- Trial
- Differences in Antihypertensive Medication Prescription Profiles Between 2009 and 2021: A Retrospective Cohort Study of CARTaGENE.Canadian journal of kidney health and disease · 2024Article
- Concomitant Treatment of Hypertensive Patients with Bisoprolol and Perindopril in Routine Clinical Practice: A Post Hoc Analysis of the CONFIDENCE II, PROTECT I, and PROTECT III Observational Studies.Advances in therapy · 2022Observational
- Compliance to Hypertension Treatment in Residents of a Fishermen Colony in District Kollam, Kerala.Nepal journal of epidemiology · 2015Article
- Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2013Article
- Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents.Current oncology (Toronto, Ont.) · 2012Article
- Characteristics, risk factors, and treatment practices of known adult hypertensive patients in saudi arabia.International journal of hypertension · 2011Article
- Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status.British journal of pharmacology · 2010Review
- Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension.The Canadian journal of cardiology · 2010Review
- The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.The Canadian journal of cardiology · 2010Review
- 2009 Canadian Hypertension Education Program recommendations: an annual update.Canadian family physician Medecin de famille canadien · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present report highlights the key messages of the 2009 Canadian Hypertension Education Program (CHEP) recommendations for the management of hypertension and the supporting clinical evidence. In 2009, the CHEP emphasizes the need to improve the control of hypertension in people with diabetes. Intensive reduction in blood pressure (to less than 130/80 mmHg) in people with diabetes leads to significant reductions in mortality rates, disability rates and overall health care system costs, and may lead to improved quality of life. The CHEP recommendations continue to emphasize the important role of patient self-efficacy by promoting lifestyle changes to prevent and control hypertension, and encouraging home measurement of blood pressure. Unfortunately, most Canadians make only minor changes in lifestyle after a diagnosis of hypertension. Routine blood pressure measurement at all appropriate visits, and screening for and management of all cardiovascular risks are key to blood pressure management. Many young hypertensive Canadians with multiple cardiovascular risks are not treated with antihypertensive drugs. This is despite the evidence that individuals with multiple cardiovascular risks and hypertension should be strongly considered for antihypertensive drug therapy regardless of age. In 2009, the CHEP specifically recommends not to combine an angiotensin-converting enzyme inhibitor with an angiotensin receptor blocker in people with uncomplicated hypertension, diabetes (without micro- or macroalbuminuria), chronic kidney disease (without nephropathy [micro- or overt proteinuria]) or ischemic heart disease (without heart failure).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.